{"id":357787,"date":"2025-08-29T11:07:21","date_gmt":"2025-08-29T11:07:21","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-alkermes\/"},"modified":"2025-08-29T11:07:21","modified_gmt":"2025-08-29T11:07:21","slug":"how-to-buy-alkermes","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/","title":{"rendered":"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334099,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-357787","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Alkermes plc (ALKS) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. G\u00fcncel hisse fiyat\u0131, kazan\u00e7 bilgileri ve 2025 i\u00e7in stratejik yat\u0131r\u0131m yakla\u015f\u0131mlar\u0131n\u0131 ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Alkermes plc (ALKS) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. G\u00fcncel hisse fiyat\u0131, kazan\u00e7 bilgileri ve 2025 i\u00e7in stratejik yat\u0131r\u0131m yakla\u015f\u0131mlar\u0131n\u0131 ke\u015ffedin."},"intro":"N\u00f6robilim tedavilerinde \u00e7\u0131\u011f\u0131r a\u00e7an bir biyofarmas\u00f6tik \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Alkermes plc (ALKS), bilimsel yenili\u011fi sa\u011flam finansal yap\u0131yla birle\u015ftiriyor\u2014sa\u011fl\u0131k sekt\u00f6r\u00fcnde b\u00fcy\u00fcme arayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Ba\u011f\u0131ml\u0131l\u0131k ve mental sa\u011fl\u0131k bozukluklar\u0131 i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedavilerle, bu \u015firket hayatlara dokunurken portf\u00f6y\u00fcn\u00fcz\u00fc de b\u00fcy\u00fctebilir.","intro_source":{"label":"Intro","type":"text","formatted_value":"N\u00f6robilim tedavilerinde \u00e7\u0131\u011f\u0131r a\u00e7an bir biyofarmas\u00f6tik \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Alkermes plc (ALKS), bilimsel yenili\u011fi sa\u011flam finansal yap\u0131yla birle\u015ftiriyor\u2014sa\u011fl\u0131k sekt\u00f6r\u00fcnde b\u00fcy\u00fcme arayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Ba\u011f\u0131ml\u0131l\u0131k ve mental sa\u011fl\u0131k bozukluklar\u0131 i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedavilerle, bu \u015firket hayatlara dokunurken portf\u00f6y\u00fcn\u00fcz\u00fc de b\u00fcy\u00fctebilir."},"body_html":"<h2>\ud83d\udcc8 Alkermes Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>29 A\u011fustos 2025 itibar\u0131yla Alkermes plc (ALKS), NASDAQ'ta <strong>29,40 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>23 Ekim 2025<\/strong> kesinlikle kritik\u2014ALKS'nin 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131 tarih. Tarihsel olarak, bu raporlar \u00f6nemli fiyat hareketleri yarat\u0131r ve ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar bundan faydalanabilir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 ALKS Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>Bu hissenin b\u00fcy\u00fck duyurulara genellikle nas\u0131l tepki verdi\u011fini g\u00f6stereyim. Son tarihsel verilere g\u00f6re, bekleyebilece\u011finiz \u015funlar:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>29 Temmuz 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>28,50 $<\/td><td><strong>%4,7 Art\u0131\u015f<\/strong> (takip eden ay)<\/td><\/tr> <tr><td>Nisan 2025<\/td><td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>27,80 $<\/td><td>%3,2 D\u00fc\u015f\u00fc\u015f (beklentiler kar\u015f\u0131lanmad\u0131)<\/td><\/tr> <tr><td>Ocak 2025<\/td><td>Y\u0131ll\u0131k Rehberlik<\/td><td>26,90 $<\/td><td>%5,1 Art\u0131\u015f (g\u00fc\u00e7l\u00fc g\u00f6r\u00fcn\u00fcm)<\/td><\/tr> <tr><td>Ekim 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>25,60 $<\/td><td>%2,8 Art\u0131\u015f (istikrarl\u0131 b\u00fcy\u00fcme)<\/td><\/tr> <tr><td>Temmuz 2024<\/td><td>\u00dcr\u00fcn Lansman\u0131<\/td><td>24,80 $<\/td><td>%6,3 Art\u0131\u015f (piyasa heyecan\u0131)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Son 2. \u00e7eyrek s\u00fcrprizi gibi pozitif s\u00fcrprizler kal\u0131c\u0131 yukar\u0131 y\u00f6nl\u00fc momentum yarat\u0131r. K\u00fc\u00e7\u00fck ka\u00e7\u0131rmalar bile sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in genellikle al\u0131m f\u0131rsat\u0131 sunan ge\u00e7ici d\u00fc\u015f\u00fc\u015flere neden olur.<\/p> <h3>6 Ayl\u0131k Fiyat Seyri (Mart-A\u011fustos 2025)<\/h3> <p>ALK hisseleri piyasa dalgalanmas\u0131na ra\u011fmen <strong>%3,44 y\u0131lba\u015f\u0131ndan beri getiri<\/strong> g\u00f6sterdi:<\/p> <ul> <li><strong>Mart<\/strong>: 27,20 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li> <li><strong>Nisan<\/strong>: 26,80 $ (1. \u00e7eyrek kazan\u00e7 hayal k\u0131r\u0131kl\u0131\u011f\u0131)<\/li> <li><strong>May\u0131s<\/strong>: 28,90 $ (iyile\u015fme d\u00f6nemi ba\u015flad\u0131)<\/li> <li><strong>Haziran<\/strong>: 29,50 $ (i\u00e7erden sat\u0131\u015f emildi)<\/li> <li><strong>Temmuz<\/strong>: 30,80 $ (2. \u00e7eyrek kazan\u00e7 sonras\u0131 y\u00fckseli\u015f)<\/li> <li><strong>A\u011fustos<\/strong>: 29,40 $ (mevcut konsolidasyon)<\/li> <\/ul> <p>Neden istikrarl\u0131 y\u00fckseli\u015f? \u00dc\u00e7 ana etken:<\/p> <ol> <li><strong>Kazan\u00e7 s\u00fcrprizleri<\/strong>: 2. \u00e7eyrek tahminleri %24 a\u015ft\u0131<\/li> <li><strong>\u0130la\u00e7 hatt\u0131 ilerlemesi<\/strong>: Narkolepsi tedavisi umut veriyor<\/li> <li><strong>Mali g\u00fc\u00e7<\/strong>: S\u0131f\u0131r bor\u00e7 ve 1 milyar dolar\u0131n \u00fczerinde nakit<\/li> <\/ol> <h3>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h3> <p><strong>2025 (Y\u0131l Sonu)<\/strong>: 32-36 $ \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br> G\u00fc\u00e7l\u00fc 3. \u00e7eyrek beklentileri ve ila\u00e7 hatt\u0131 ilerlemeleri Aral\u0131k ay\u0131na kadar %15-20 y\u00fckseli\u015f potansiyeli g\u00f6steriyor.<\/p> <p><strong>2026<\/strong>: 38-42 $<br> Mevcut \u00fcr\u00fcnlerin piyasa geni\u015flemesi ve narkolepsi tedavisinin onay\u0131 \u00f6nemli b\u00fcy\u00fcme sa\u011flayabilir.<\/p> <p><strong>2028<\/strong>: 45-52 $<br> 2028'e kadar birden fazla \u00fcr\u00fcn lansman\u0131 ve yeni n\u00f6rolojik bozukluklara geni\u015fleme bekleniyor.<\/p> <p><strong>2030<\/strong>: 55-65 $<br> Ba\u011f\u0131ml\u0131l\u0131k tedavisi ve uyku bozukluklar\u0131nda uzun vadeli hakimiyet ALKS'yi sekt\u00f6r lideri yapabilir.<\/p> <p><strong>Sonu\u00e7<\/strong>: <strong>Uzun vadeli birikim<\/strong> i\u00e7in ideal. K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar 23 Ekim civar\u0131ndaki kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015fleri izlemeli.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: FDA onaylar\u0131 \u00f6ng\u00f6r\u00fclemez olabilir<\/li> <li><strong>\u0130la\u00e7 hatt\u0131 ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: Narkolepsi ilac\u0131n\u0131n ba\u015far\u0131s\u0131na y\u00fcksek ba\u011fl\u0131l\u0131k<\/li> <li><strong>Rekabet<\/strong>: Takeda ve di\u011ferleri uyku bozukluklar\u0131 alan\u0131nda<\/li> <li><strong>Piyasa volatilitesi<\/strong>: Biyotek hisse senetleri haberlerle sert dalgalanabilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Kazan\u00e7 ivmesi<\/strong>: S\u00fcrekli tahminleri a\u015fma (<a href=\"https:\/\/www.nasdaq.com\/articles\/alkermes-q2-earnings-beat-estimates-proprietary-drugs-aid-sales\">2. \u00c7eyrek Kazan\u00e7 Analizi<\/a>)<\/li> <li><strong>Nakit pozisyonu<\/strong>: 1 milyar $+ bor\u00e7suzluk istikrar sa\u011flar<\/li> <li><strong>Sekt\u00f6r trendi<\/strong>: Mental sa\u011fl\u0131k tedavisi talebi y\u0131lda %12 art\u0131yor<\/li> <li><strong>Son ba\u015far\u0131<\/strong>: Vibrance-1 Faz 2 sonu\u00e7lar\u0131 beklentileri a\u015ft\u0131<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10'unu ALKS'ye ay\u0131rarak ba\u015flay\u0131n<\/li> <li><strong>Ortalama maliyetle al\u0131m<\/strong>: Kazan\u00e7 tarihleri civar\u0131nda par\u00e7a par\u00e7a al\u0131m yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: 28 $ destek ve 30 $ diren\u00e7 \u00f6nemli seviyeler<\/li> <li><strong>23 Ekim'i takip edin<\/strong>: 3. \u00e7eyrek kazan\u00e7lar\u0131 b\u00fcy\u00fck kataliz\u00f6r olabilir<\/li> <\/ol> <p>Espiri: \"ALKS ticareti, ba\u011f\u0131ml\u0131l\u0131k tedavileri gibi\u2014sab\u0131r ve dikkatli dozaj gerektirir. Acele ederseniz finansal rehabilitasyona ihtiyac\u0131n\u0131z olabilir!\"<\/p> <h2>\u2705 Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve makul \u00fccretler sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"ALKS\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limit emirleri volatilitede a\u015f\u0131r\u0131 \u00f6deme riskini azalt\u0131r<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon oranlar\u0131n\u0131 kontrol edin\u2014%1'in alt\u0131nda hedefleyin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonunuzu izleyin<\/td><td>Giri\u015f fiyat\u0131n\u0131n %10-15 alt\u0131nda stop-loss koyun<\/td><\/tr> <tr><td>7<\/td><td>Temett\u00fcleri yeniden yat\u0131r\u0131n<\/td><td>ALKS temett\u00fc \u00f6demez\u2014b\u00fcy\u00fcmeye odaklan\u0131n<\/td><\/tr> <tr><td>8<\/td><td>Bilgi sahibi olun<\/td><td>Kazan\u00e7 tarihleri ve FDA duyurular\u0131n\u0131 takip edin<\/td><\/tr> <tr><td>9<\/td><td>Vergi etkilerini d\u00fc\u015f\u00fcn\u00fcn<\/td><td>1 y\u0131ldan fazla tutarak daha iyi sermaye kazanc\u0131 avantaj\u0131 sa\u011flay\u0131n<\/td><\/tr> <tr><td>10<\/td><td>\u00dc\u00e7 ayda bir g\u00f6zden ge\u00e7irin<\/td><td>Her kazan\u00e7 raporundan sonra pozisyonunuzu yeniden de\u011ferlendirin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni ALKS Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>Pocket Option, ila\u00e7 hisse senedi piyasas\u0131na giri\u015fte herkese eri\u015fim sa\u011flar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> \u2014 ALKS ile stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li> <li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda do\u011frulama<\/strong> \u2014 Herhangi bir kimlik belgesini y\u00fckleyin ve dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 kripto, e-c\u00fczdan ve banka transferleri dahil<\/li> <li><strong>Ger\u00e7ek zamanl\u0131 NASDAQ verisi<\/strong> \u2014 ALKS giri\u015f zamanlamas\u0131 i\u00e7in kritik<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli sayesinde ALKS pozisyonunuzu kademeli olarak olu\u015fturabilir, d\u00fc\u015f\u00fc\u015flerde hisse ekleyebilir ve hissenin volatilitesinden faydalanabilirsiniz.<\/p> <h2>\ud83c\udf0d Alkermes 2025'te: N\u00f6robilim Yenilik\u00e7isi<\/h2> <p>Alkermes, Vivitrol ile ba\u011f\u0131ml\u0131l\u0131k tedavi pazar\u0131nda lider konumda olup, umut vadeden narkolepsi tedavisiyle uyku bozukluklar\u0131na da geni\u015fliyor. \u015eirket, <strong>bor\u00e7suz ve 1 milyar dolar\u0131n \u00fczerinde nakit<\/strong> ile sa\u011flam finansal pozisyonunu koruyor (<a href=\"https:\/\/www.ainvest.com\/news\/alkermes-reports-q2-2025-earnings-strong-growth-pipeline-advancements-strategic-positioning-2508\/\">2. \u00c7eyrek 2025 Raporu<\/a>), biyotek sekt\u00f6r\u00fcndeki volatiliteye kar\u015f\u0131 ola\u011fan\u00fcst\u00fc istikrar sa\u011fl\u0131yor.<\/p> <p><strong>2025 e\u011flenceli bilgi<\/strong>: Alkermes ara\u015ft\u0131rmac\u0131lar\u0131, narkolepsi ilac\u0131 adaylar\u0131n\u0131n uyku yoksunlu\u011fu ya\u015fayan sa\u011fl\u0131k profesyonellerinde bili\u015fsel fonksiyonlar\u0131 iyile\u015ftirme potansiyeli oldu\u011funu ke\u015ffettiler\u2014s\u00f6ylediklerini uygulamak gibi!<\/p> <h3>Mevcut Piyasa Konumu<\/h3> <ul> <li><strong>Piyasa de\u011feri<\/strong>: 4,91 milyar $<\/li> <li><strong>\u00c7al\u0131\u015fan say\u0131s\u0131<\/strong>: D\u00fcnya \u00e7ap\u0131nda 1.800<\/li> <li><strong>Merkez<\/strong>: Dublin, \u0130rlanda (\u00f6nemli ABD operasyonlar\u0131 ile)<\/li> <li><strong>Ana \u00fcr\u00fcnler<\/strong>: Vivitrol, Aristada, Lybalvi<\/li> <li><strong>Ar-Ge odak<\/strong>: N\u00f6rolojik ve psikiyatrik bozukluklar<\/li> <\/ul> <p>\u015eirketin uyku bozukluklar\u0131na y\u00f6nelik stratejik kay\u0131\u015f\u0131 b\u00fcy\u00fck bir b\u00fcy\u00fcme f\u0131rsat\u0131 sunuyor; k\u00fcresel narkolepsi tedavi pazar\u0131n\u0131n 2028'e kadar 4,5 milyar $'a ula\u015fmas\u0131 bekleniyor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Alkermes Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>29 A\u011fustos 2025 itibar\u0131yla Alkermes plc (ALKS), NASDAQ&#8217;ta <strong>29,40 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>23 Ekim 2025<\/strong> kesinlikle kritik\u2014ALKS&#8217;nin 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131 tarih. Tarihsel olarak, bu raporlar \u00f6nemli fiyat hareketleri yarat\u0131r ve ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar bundan faydalanabilir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 ALKS Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>Bu hissenin b\u00fcy\u00fck duyurulara genellikle nas\u0131l tepki verdi\u011fini g\u00f6stereyim. Son tarihsel verilere g\u00f6re, bekleyebilece\u011finiz \u015funlar:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>29 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>28,50 $<\/td>\n<td><strong>%4,7 Art\u0131\u015f<\/strong> (takip eden ay)<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>27,80 $<\/td>\n<td>%3,2 D\u00fc\u015f\u00fc\u015f (beklentiler kar\u015f\u0131lanmad\u0131)<\/td>\n<\/tr>\n<tr>\n<td>Ocak 2025<\/td>\n<td>Y\u0131ll\u0131k Rehberlik<\/td>\n<td>26,90 $<\/td>\n<td>%5,1 Art\u0131\u015f (g\u00fc\u00e7l\u00fc g\u00f6r\u00fcn\u00fcm)<\/td>\n<\/tr>\n<tr>\n<td>Ekim 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>25,60 $<\/td>\n<td>%2,8 Art\u0131\u015f (istikrarl\u0131 b\u00fcy\u00fcme)<\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2024<\/td>\n<td>\u00dcr\u00fcn Lansman\u0131<\/td>\n<td>24,80 $<\/td>\n<td>%6,3 Art\u0131\u015f (piyasa heyecan\u0131)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Son 2. \u00e7eyrek s\u00fcrprizi gibi pozitif s\u00fcrprizler kal\u0131c\u0131 yukar\u0131 y\u00f6nl\u00fc momentum yarat\u0131r. K\u00fc\u00e7\u00fck ka\u00e7\u0131rmalar bile sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in genellikle al\u0131m f\u0131rsat\u0131 sunan ge\u00e7ici d\u00fc\u015f\u00fc\u015flere neden olur.<\/p>\n<h3>6 Ayl\u0131k Fiyat Seyri (Mart-A\u011fustos 2025)<\/h3>\n<p>ALK hisseleri piyasa dalgalanmas\u0131na ra\u011fmen <strong>%3,44 y\u0131lba\u015f\u0131ndan beri getiri<\/strong> g\u00f6sterdi:<\/p>\n<ul>\n<li><strong>Mart<\/strong>: 27,20 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li>\n<li><strong>Nisan<\/strong>: 26,80 $ (1. \u00e7eyrek kazan\u00e7 hayal k\u0131r\u0131kl\u0131\u011f\u0131)<\/li>\n<li><strong>May\u0131s<\/strong>: 28,90 $ (iyile\u015fme d\u00f6nemi ba\u015flad\u0131)<\/li>\n<li><strong>Haziran<\/strong>: 29,50 $ (i\u00e7erden sat\u0131\u015f emildi)<\/li>\n<li><strong>Temmuz<\/strong>: 30,80 $ (2. \u00e7eyrek kazan\u00e7 sonras\u0131 y\u00fckseli\u015f)<\/li>\n<li><strong>A\u011fustos<\/strong>: 29,40 $ (mevcut konsolidasyon)<\/li>\n<\/ul>\n<p>Neden istikrarl\u0131 y\u00fckseli\u015f? \u00dc\u00e7 ana etken:<\/p>\n<ol>\n<li><strong>Kazan\u00e7 s\u00fcrprizleri<\/strong>: 2. \u00e7eyrek tahminleri %24 a\u015ft\u0131<\/li>\n<li><strong>\u0130la\u00e7 hatt\u0131 ilerlemesi<\/strong>: Narkolepsi tedavisi umut veriyor<\/li>\n<li><strong>Mali g\u00fc\u00e7<\/strong>: S\u0131f\u0131r bor\u00e7 ve 1 milyar dolar\u0131n \u00fczerinde nakit<\/li>\n<\/ol>\n<h3>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h3>\n<p><strong>2025 (Y\u0131l Sonu)<\/strong>: 32-36 $ \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> G\u00fc\u00e7l\u00fc 3. \u00e7eyrek beklentileri ve ila\u00e7 hatt\u0131 ilerlemeleri Aral\u0131k ay\u0131na kadar %15-20 y\u00fckseli\u015f potansiyeli g\u00f6steriyor.<\/p>\n<p><strong>2026<\/strong>: 38-42 $<br \/> Mevcut \u00fcr\u00fcnlerin piyasa geni\u015flemesi ve narkolepsi tedavisinin onay\u0131 \u00f6nemli b\u00fcy\u00fcme sa\u011flayabilir.<\/p>\n<p><strong>2028<\/strong>: 45-52 $<br \/> 2028&#8217;e kadar birden fazla \u00fcr\u00fcn lansman\u0131 ve yeni n\u00f6rolojik bozukluklara geni\u015fleme bekleniyor.<\/p>\n<p><strong>2030<\/strong>: 55-65 $<br \/> Ba\u011f\u0131ml\u0131l\u0131k tedavisi ve uyku bozukluklar\u0131nda uzun vadeli hakimiyet ALKS&#8217;yi sekt\u00f6r lideri yapabilir.<\/p>\n<p><strong>Sonu\u00e7<\/strong>: <strong>Uzun vadeli birikim<\/strong> i\u00e7in ideal. K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar 23 Ekim civar\u0131ndaki kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015fleri izlemeli.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: FDA onaylar\u0131 \u00f6ng\u00f6r\u00fclemez olabilir<\/li>\n<li><strong>\u0130la\u00e7 hatt\u0131 ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: Narkolepsi ilac\u0131n\u0131n ba\u015far\u0131s\u0131na y\u00fcksek ba\u011fl\u0131l\u0131k<\/li>\n<li><strong>Rekabet<\/strong>: Takeda ve di\u011ferleri uyku bozukluklar\u0131 alan\u0131nda<\/li>\n<li><strong>Piyasa volatilitesi<\/strong>: Biyotek hisse senetleri haberlerle sert dalgalanabilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Kazan\u00e7 ivmesi<\/strong>: S\u00fcrekli tahminleri a\u015fma (<a href=\"https:\/\/www.nasdaq.com\/articles\/alkermes-q2-earnings-beat-estimates-proprietary-drugs-aid-sales\">2. \u00c7eyrek Kazan\u00e7 Analizi<\/a>)<\/li>\n<li><strong>Nakit pozisyonu<\/strong>: 1 milyar $+ bor\u00e7suzluk istikrar sa\u011flar<\/li>\n<li><strong>Sekt\u00f6r trendi<\/strong>: Mental sa\u011fl\u0131k tedavisi talebi y\u0131lda %12 art\u0131yor<\/li>\n<li><strong>Son ba\u015far\u0131<\/strong>: Vibrance-1 Faz 2 sonu\u00e7lar\u0131 beklentileri a\u015ft\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10&#8217;unu ALKS&#8217;ye ay\u0131rarak ba\u015flay\u0131n<\/li>\n<li><strong>Ortalama maliyetle al\u0131m<\/strong>: Kazan\u00e7 tarihleri civar\u0131nda par\u00e7a par\u00e7a al\u0131m yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: 28 $ destek ve 30 $ diren\u00e7 \u00f6nemli seviyeler<\/li>\n<li><strong>23 Ekim&#8217;i takip edin<\/strong>: 3. \u00e7eyrek kazan\u00e7lar\u0131 b\u00fcy\u00fck kataliz\u00f6r olabilir<\/li>\n<\/ol>\n<p>Espiri: &#8220;ALKS ticareti, ba\u011f\u0131ml\u0131l\u0131k tedavileri gibi\u2014sab\u0131r ve dikkatli dozaj gerektirir. Acele ederseniz finansal rehabilitasyona ihtiyac\u0131n\u0131z olabilir!&#8221;<\/p>\n<h2>\u2705 Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul \u00fccretler sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;ALKS&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri volatilitede a\u015f\u0131r\u0131 \u00f6deme riskini azalt\u0131r<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon oranlar\u0131n\u0131 kontrol edin\u2014%1&#8217;in alt\u0131nda hedefleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonunuzu izleyin<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131n %10-15 alt\u0131nda stop-loss koyun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Temett\u00fcleri yeniden yat\u0131r\u0131n<\/td>\n<td>ALKS temett\u00fc \u00f6demez\u2014b\u00fcy\u00fcmeye odaklan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Bilgi sahibi olun<\/td>\n<td>Kazan\u00e7 tarihleri ve FDA duyurular\u0131n\u0131 takip edin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Vergi etkilerini d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>1 y\u0131ldan fazla tutarak daha iyi sermaye kazanc\u0131 avantaj\u0131 sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u00dc\u00e7 ayda bir g\u00f6zden ge\u00e7irin<\/td>\n<td>Her kazan\u00e7 raporundan sonra pozisyonunuzu yeniden de\u011ferlendirin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni ALKS Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>Pocket Option, ila\u00e7 hisse senedi piyasas\u0131na giri\u015fte herkese eri\u015fim sa\u011flar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> \u2014 ALKS ile stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li>\n<li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda do\u011frulama<\/strong> \u2014 Herhangi bir kimlik belgesini y\u00fckleyin ve dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 kripto, e-c\u00fczdan ve banka transferleri dahil<\/li>\n<li><strong>Ger\u00e7ek zamanl\u0131 NASDAQ verisi<\/strong> \u2014 ALKS giri\u015f zamanlamas\u0131 i\u00e7in kritik<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli sayesinde ALKS pozisyonunuzu kademeli olarak olu\u015fturabilir, d\u00fc\u015f\u00fc\u015flerde hisse ekleyebilir ve hissenin volatilitesinden faydalanabilirsiniz.<\/p>\n<h2>\ud83c\udf0d Alkermes 2025&#8217;te: N\u00f6robilim Yenilik\u00e7isi<\/h2>\n<p>Alkermes, Vivitrol ile ba\u011f\u0131ml\u0131l\u0131k tedavi pazar\u0131nda lider konumda olup, umut vadeden narkolepsi tedavisiyle uyku bozukluklar\u0131na da geni\u015fliyor. \u015eirket, <strong>bor\u00e7suz ve 1 milyar dolar\u0131n \u00fczerinde nakit<\/strong> ile sa\u011flam finansal pozisyonunu koruyor (<a href=\"https:\/\/www.ainvest.com\/news\/alkermes-reports-q2-2025-earnings-strong-growth-pipeline-advancements-strategic-positioning-2508\/\">2. \u00c7eyrek 2025 Raporu<\/a>), biyotek sekt\u00f6r\u00fcndeki volatiliteye kar\u015f\u0131 ola\u011fan\u00fcst\u00fc istikrar sa\u011fl\u0131yor.<\/p>\n<p><strong>2025 e\u011flenceli bilgi<\/strong>: Alkermes ara\u015ft\u0131rmac\u0131lar\u0131, narkolepsi ilac\u0131 adaylar\u0131n\u0131n uyku yoksunlu\u011fu ya\u015fayan sa\u011fl\u0131k profesyonellerinde bili\u015fsel fonksiyonlar\u0131 iyile\u015ftirme potansiyeli oldu\u011funu ke\u015ffettiler\u2014s\u00f6ylediklerini uygulamak gibi!<\/p>\n<h3>Mevcut Piyasa Konumu<\/h3>\n<ul>\n<li><strong>Piyasa de\u011feri<\/strong>: 4,91 milyar $<\/li>\n<li><strong>\u00c7al\u0131\u015fan say\u0131s\u0131<\/strong>: D\u00fcnya \u00e7ap\u0131nda 1.800<\/li>\n<li><strong>Merkez<\/strong>: Dublin, \u0130rlanda (\u00f6nemli ABD operasyonlar\u0131 ile)<\/li>\n<li><strong>Ana \u00fcr\u00fcnler<\/strong>: Vivitrol, Aristada, Lybalvi<\/li>\n<li><strong>Ar-Ge odak<\/strong>: N\u00f6rolojik ve psikiyatrik bozukluklar<\/li>\n<\/ul>\n<p>\u015eirketin uyku bozukluklar\u0131na y\u00f6nelik stratejik kay\u0131\u015f\u0131 b\u00fcy\u00fck bir b\u00fcy\u00fcme f\u0131rsat\u0131 sunuyor; k\u00fcresel narkolepsi tedavi pazar\u0131n\u0131n 2028&#8217;e kadar 4,5 milyar $&#8217;a ula\u015fmas\u0131 bekleniyor.<\/p>\n"},"faq":[{"question":"Alkermes plc hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlay\u0131n, \"ALKS\" sembol\u00fc ile arama yap\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylay\u0131n. Pozisyonunuzu d\u00fczenli olarak izleyin ve kazan\u00e7 raporlar\u0131n\u0131 takip edin."},{"question":"Alkermes hisseleri i\u00e7in \u00f6nemli kazan\u00e7 tarihleri nelerdir?","answer":"\u00d6zellikle 23 Ekim 2025'te 3. \u00e7eyrek kazan\u00e7 raporu a\u00e7\u0131klanacak. Bu t\u00fcr tarihler hisse fiyat\u0131nda \u00f6nemli hareketlere neden olabilir."},{"question":"Alkermes'in finansal durumu nas\u0131l?","answer":"\u015eirket bor\u00e7suzdur ve 1 milyar dolar\u0131n \u00fczerinde nakit rezervine sahiptir, bu da finansal istikrar sa\u011flar."},{"question":"Alkermes'in b\u00fcy\u00fcme potansiyeli nedir?","answer":"Narkolepsi tedavisi ve di\u011fer n\u00f6rolojik bozukluklara y\u00f6nelik \u00fcr\u00fcn geli\u015ftirme ile 2025-2030 aras\u0131nda g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme beklenmektedir."},{"question":"Yeni ba\u015flayanlar ALKS hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131yla ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yaparak al\u0131m yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve \u00f6nemli kazan\u00e7 tarihlerini takip edin."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Alkermes plc hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlay\u0131n, \"ALKS\" sembol\u00fc ile arama yap\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylay\u0131n. Pozisyonunuzu d\u00fczenli olarak izleyin ve kazan\u00e7 raporlar\u0131n\u0131 takip edin."},{"question":"Alkermes hisseleri i\u00e7in \u00f6nemli kazan\u00e7 tarihleri nelerdir?","answer":"\u00d6zellikle 23 Ekim 2025'te 3. \u00e7eyrek kazan\u00e7 raporu a\u00e7\u0131klanacak. Bu t\u00fcr tarihler hisse fiyat\u0131nda \u00f6nemli hareketlere neden olabilir."},{"question":"Alkermes'in finansal durumu nas\u0131l?","answer":"\u015eirket bor\u00e7suzdur ve 1 milyar dolar\u0131n \u00fczerinde nakit rezervine sahiptir, bu da finansal istikrar sa\u011flar."},{"question":"Alkermes'in b\u00fcy\u00fcme potansiyeli nedir?","answer":"Narkolepsi tedavisi ve di\u011fer n\u00f6rolojik bozukluklara y\u00f6nelik \u00fcr\u00fcn geli\u015ftirme ile 2025-2030 aras\u0131nda g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme beklenmektedir."},{"question":"Yeni ba\u015flayanlar ALKS hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131yla ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yaparak al\u0131m yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve \u00f6nemli kazan\u00e7 tarihlerini takip edin."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T11:07:21+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-29T11:07:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/\",\"name\":\"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"datePublished\":\"2025-08-29T11:07:21+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/","og_locale":"tr_TR","og_type":"article","og_title":"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T11:07:21+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-29T11:07:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/","name":"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","datePublished":"2025-08-29T11:07:21+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alkermes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Alkermes plc (ALKS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Alkermes plc (ALKS) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":357788,"slug":"how-to-buy-alkermes","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alkermes plc (ALKS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alkermes plc (ALKS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alkermes\/"},"pt_AA":{"locale":"pt_AA","id":357792,"slug":"how-to-buy-alkermes","post_title":"Como comprar a\u00e7\u00f5es da Alkermes plc (ALKS) - Investimento em a\u00e7\u00f5es da Alkermes plc (ALKS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-alkermes\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/357787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=357787"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/357787\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334099"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=357787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=357787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=357787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}